78
57
Growth Score
-8 pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
337339
BioCAD is a full-cycle drug development and manufacturing company with a world-class research and development center.
Acquired by 
Molecular Simulations, Inc.
- Ivan Alvovsky: Medical expert (Oncology)
- Alexandr Grachev: Deputy CEO
About the Company
BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological manufacturing facilities, as well as preclinical and clinical research infrastructure compliant with international standards.
